Encysive Pharma

Related by string. * : Encysive Pharmaceuticals Nasdaq ENCY . Encysive Pharmaceuticals ENCY . PRNewswire FirstCall Encysive Pharmaceuticals . Encysive surged . Encysive undertakes . Encysive Pharmaceuticals Inc. . Encysive Pharmaceuticals / pharmas . Pharmas . pharma . PHARMA : pharma ceutical . Sun Pharma . pharma biotech . Omega Pharma Lotto . Elder Pharma . Omega Pharma * *

Related by context. Frequent words. (Click for all words.) 70 Hanger Orthopedic 69 Q2 Profit Surges 68 POZN 68 THRX 68 AUXL 68 MDVN 68 Cephalon CEPH 68 OPTR 68 ALTH 67 ENZN 67 BPAX 67 VPHM 67 Questcor Pharmaceuticals 67 Lowers Guidance 67 Protalix BioTherapeutics 66 CADX 66 Zions Bancorporation ZION 66 Rexahn Pharmaceuticals 66 FY# Guidance 66 ISTA Pharmaceuticals 66 SXCI 66 DYAX 66 INCY 66 SNTS 66 AMRN 66 HITK 66 AMAG Pharmaceuticals 66 Savient Pharmaceuticals 66 Anika Therapeutics 65 ISPH 65 VICL 65 AKRX 65 Rockwell Automation ROK 65 Analyst Upgrade 65 Cholesterol Drug 65 Teva Pharma 65 Abbott ABT 65 SEPR 65 ONXX 65 SGEN 65 BRKS 65 PRXL 65 lululemon athletica inc 65 Wintrust Financial 65 VNDA 65 SVNT 64 Teva Pharmaceutical TEVA 64 IDIX 64 Newell Rubbermaid NWL 64 MNKD 64 CRXX 64 BioDelivery Sciences 64 Somaxon Pharmaceuticals 64 IMMU 64 Idenix Pharmaceuticals 64 NBIX 64 Halozyme Therapeutics 64 Q1 Loss Narrows 64 PVTB 64 Dycom Industries 64 SCLN 64 MELA Sciences 64 Allegiant Travel 64 Q2 Loss Narrows 64 CYBX 64 Endurance Specialty 64 Calls Purchased 64 SciClone Pharmaceuticals 64 Cardiome Pharma 64 Guides FY# Quick Facts 64 BioMarin Pharmaceutical 64 Anadys Pharmaceuticals 64 Amylin Pharmaceuticals AMLN 64 ACADIA Pharmaceuticals 63 RPRX 63 Ardea Biosciences 63 Premarket Movers 63 Gilead Sciences NASDAQ GILD 63 AVII 63 Altra Holdings 63 QCOR 63 BioSante Pharmaceuticals 63 PRGO 63 Q1 Loss Widens 63 MRGE 63 Guides Q2 63 Bristol Myers BMY 63 SHPGY 63 Patient Enrollment 63 Optimer Pharmaceuticals 63 SOMX 63 MDCO 63 CYTX 63 IGTE 63 CRME 63 AVANIR Pharmaceuticals 63 SLXP 63 Cantel Medical 63 Corcept Therapeutics 63 Mylan Labs 63 Q3 Loss Narrows

Back to home page